Ophthotech Stock Price (NASDAQ:OPHT)

Add to My Stocks
$2.71 $0.07 (2.65%) OPHT stock closing price Jul 26, 2017 (Closing)
Prev Close* : $2.64
Market Cap:
$94.65M
Day Low: $2.69
52 Week Low: $2.24
Open: $2.7
Volume: 861266
Day High: $2.89
52 Week High: $65.96
Dividend:
N/A

Latest Stock Market News

Latest Articles

Ophthotech News - From Partners

3 Great Stocks to Beat the Biotech Blues   by Zacks on Dec 13, 2016

OPHT Stockcharts

View OPHT PE ratio, PS ratio stocks charts and compare with peers.
OPHT Chart
Note: Compare Ophthotech stock price history with the index and industry peers.

Ophthotech Valuation

PS ratio (
price to sales ratio
)
2.63

Ophthotech Financial Ratios

Asset Turnover
0.03
Receivables Turnover
2.46

OPHT Industry Peers

Company Price Change (%)
Pfenex (PFNX)4.770.08 (1.65%)
Alimera Sciences (ALIM)1.450 (0%)
Regeneron Pharma (REGN)515.632.18 (0.42%)
Tracon Pharma (TCON)2.250.05 (2.27%)
Novartis (NVS)84.850.65 (0.77%)
Adverum (ADVM)2.60 (0%)
Clearside Biomedical (CLSD)9.170.13 (1.4%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)39.652.32 (6.21%)
Dynavax Technologies (DVAX)10.40.5 (5.05%)
MannKind (MNKD)1.320.06 (4.76%)
BioDelivery Sciences (BDSI)3.50.15 (4.48%)
Biogen Inc (BIIB)295.6112.65 (4.47%)
Paratek Pharma (PRTK)21.450.85 (4.13%)
Vital Therapies (VTL)2.750.1 (3.77%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017
CompanyPriceChange (%)
Integra LifeSciences (IART)49.745.88 (10.57%)
Idera Pharma (IDRA)1.940.12 (5.83%)
Kamada (KMDA)5.150.25 (4.63%)
Peregrine Pharma (PPHM)4.30.2 (4.44%)
Fate Therapeutics (FATE)2.830.11 (3.74%)
Compugen (CGEN)3.90.15 (3.7%)
Trevena (TRVN)2.720.1 (3.55%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017

Ophthotech Corp Stock News - Partner Headlines

Ophthotech Financial Statements

income statement20162015201420132012
Net Sales Or Revenues50.9M51.5M41.25M--
Net Income-193.42M-105.71M-98.18M-51.14M-14.56M
Total Operating Expense246.46M175.03M121.76M47.42M13.67M
view Ophthotech Corp income statement
balance sheet20162015201420132012
Total Assets299.63M428.85M498.37M217.68M4.87M
Total Liabilities394.24M368.9M351.24M47.96M128.34M
Shareholders Equity-94.61M59.94M147.12M169.72M-123.47M
view Ophthotech Corp balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities28M21.01M218.09M-3.01M0.33M
Net Cash From (Used By) Operating Activities-108.59M-78.53M111.08M-48.77M-13.1M
Increase (Decrease) In Prop Plant And Equipment-0.57M-2.6M-1.65M-0.01M-
view Ophthotech Corp cashflow statement

Ophthotech Stock Message Board

Ophthotech stock lost 2.65 %, and the last close price as of 26 Jul, 2017 is 2.71 for OPHT stock. Looking at Ophthotech market capitalization, which currently stands at 94.65M, we can say that OPHT stock is a Micro cap stock. Ophthotech valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Ophthotech stock price and Ophthotech share price mean the same thing. 861266 shares were traded with a closing stock price of 2.71 as of 26 Jul, 2017, as can be seen from Ophthotech stock quote. One can view Ophthotech stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of OPHT, view Ophthotech stock price history.